Swiss fertility tracking startup Ava closes $10 million Series A funding round
Share on Facebook
Share on Twitter
Share on Google+
Share on Reddit
Share on Email

Photo credit: Ava

Photo credit: Ava

Ava’s wearable helps women determine their fertile window

Tech.eu

Ava, a Swiss medical technology company focused on innovations in women’s health, has raised $9.7 million in a strategic Series A round led by European VC firm Polytech Ecosystem Ventures. The funds will fuel further product development and clinical research, scale production and support expansion into Europe and other new markets.

The Ava bracelet uses a patented big data approach to precisely detect a woman’s entire fertile window in real time. The company is working on clinical studies to expand its algorithms for use in both pregnancy recognition, pregnancy monitoring, and possible use as a non-­hormonal contraceptive device. With research and product development based in Zurich, Ava’s US headquarters are in San Francisco.

Read more: Startupticker.ch

This post was originally published on Tech.eu

Share on:Share
Share on Facebook
Share on Twitter
Share on Google+
Share on Reddit
Share on Email
Shaheen Samavati

About Shaheen Samavati


Shaheen is a seasoned business journalist with 10 years of experience in reporting. She worked for 3 years as a staff business reporter at The Plain Dealer, and has contributed to the likes of The Wall Street Journal, LatinFinance and others. Shaheen holds an MBA from IE Business School in Madrid.

More Goodies From Funding


Top 10 Philadelphia startups ring loudly

Top 10 Kansas City startups spread across two states

What does your car have to say about you?